|
Name |
Carazolol
|
Molecular Formula | C18H22N2O2 | |
IUPAC Name* |
1-(9H-carbazol-4-yloxy)-3-(propan-2-ylamino)propan-2-ol
|
|
SMILES |
CC(C)NCC(COC1=CC=CC2=C1C3=CC=CC=C3N2)O
|
|
InChI |
InChI=1S/C18H22N2O2/c1-12(2)19-10-13(21)11-22-17-9-5-8-16-18(17)14-6-3-4-7-15(14)20-16/h3-9,12-13,19-21H,10-11H2,1-2H3
|
|
InChIKey |
BQXQGZPYHWWCEB-UHFFFAOYSA-N
|
|
Synonyms |
Carazolol; 57775-29-8; Conducton; Suacron; 1-(Carbazol-4-yloxy)-3-(isopropylamino)-2-propanol; BM 51052; corazolol; 1-((9H-Carbazol-4-yl)oxy)-3-(isopropylamino)propan-2-ol; 1-(9H-carbazol-4-yloxy)-3-(propan-2-ylamino)propan-2-ol; BM-51052; Conducton hydrochloride; CHEMBL324665; 2-Propanol, 1-(9H-carbazol-4-yloxy)-3-[(1-methylethyl)amino]-; 29PW75S82A; Carazolol (INN); Carazolol 100 microg/mL in Acetonitrile; CARAZOLOL [INN]; Carazololum; Carazolol [INN:BAN]; 2-Propanol, 1-(9H-carbazol-4-yloxy)-3-((1-methylethyl)amino)-; Carazololum [INN-Latin]; CCRIS 1047; 1-(9H-carbazol-4-yloxy)-3-(isopropylamino)propan-2-ol; EINECS 260-945-1; BRN 3620576; UNII-29PW75S82A; Conducton (TN); 1-(4-Carbazolyloxy)-3-isopropylamino-2-propanol; 4-(2-Hydroxy-3-isopropylamino-propoxy)-carbazole; 1-(9H-Carbazol-4-yloxy-3-((1-methylethyl)amino)-2-propanol); CARAZOLOL [MI]; CARAZOLOL [MART.]; CARAZOLOL [WHO-DD]; (isopropylamino)propan-2-ol; Suacron [veterinary] (TN); SCHEMBL77901; SCHEMBL77902; GTPL569; MLS006010892; Carazolol, analytical standard; 1-(9H-Carbazol-4-yloxy)-3-(isopropylamino)-2-propanol; DTXSID00866648; 1-(9H-carbazol-4-yloxy)-3-; CHEBI:135261; NNNN-TETRAETHYLISOPHTHALAMIDE; BDBM50027663; s6447; AKOS027320502; SB66991; LS-14657; SMR002529709; Carazolol 1000 microg/mL in Acetonitrile; HY-107327; CS-0028150; FT-0601602; 75C298; D07608; T71087; A831600; L000159; Q5037818; 1-(9H-Carbazol-4-yloxy)-3-isopropylamino-propan-2-ol; 1-(9H-Carbazol-4-yloxy)-3-(isopropylamino)-2-propanol #; 1-(9H-Carbazol-4-yloxy)-3-isopropylamino-propan-2-ol(carazolol)
|
|
CAS | 57775-29-8 | |
PubChem CID | 71739 | |
ChEMBL ID | CHEMBL324665 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 298.4 | ALogp: | 3.6 |
HBD: | 3 | HBA: | 3 |
Rotatable Bonds: | 6 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 57.3 | Aromatic Rings: | 3 |
Heavy Atoms: | 22 | QED Weighted: | 0.648 |
Caco-2 Permeability: | -5.138 | MDCK Permeability: | 0.00000988 |
Pgp-inhibitor: | 0.003 | Pgp-substrate: | 0.988 |
Human Intestinal Absorption (HIA): | 0.028 | 20% Bioavailability (F20%): | 0.002 |
30% Bioavailability (F30%): | 0.008 |
Blood-Brain-Barrier Penetration (BBB): | 0.649 | Plasma Protein Binding (PPB): | 81.93% |
Volume Distribution (VD): | 2.507 | Fu: | 13.26% |
CYP1A2-inhibitor: | 0.982 | CYP1A2-substrate: | 0.883 |
CYP2C19-inhibitor: | 0.178 | CYP2C19-substrate: | 0.84 |
CYP2C9-inhibitor: | 0.019 | CYP2C9-substrate: | 0.56 |
CYP2D6-inhibitor: | 0.909 | CYP2D6-substrate: | 0.923 |
CYP3A4-inhibitor: | 0.144 | CYP3A4-substrate: | 0.719 |
Clearance (CL): | 10.673 | Half-life (T1/2): | 0.281 |
hERG Blockers: | 0.605 | Human Hepatotoxicity (H-HT): | 0.179 |
Drug-inuced Liver Injury (DILI): | 0.022 | AMES Toxicity: | 0.103 |
Rat Oral Acute Toxicity: | 0.66 | Maximum Recommended Daily Dose: | 0.894 |
Skin Sensitization: | 0.766 | Carcinogencity: | 0.232 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.014 |
Respiratory Toxicity: | 0.938 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001521 | 0.446 | D04JEE | 0.696 | ||||
ENC000074 | 0.402 | D0F2PO | 0.606 | ||||
ENC002323 | 0.372 | D0W9LX | 0.557 | ||||
ENC005446 | 0.364 | D0X2MB | 0.487 | ||||
ENC000663 | 0.360 | D0H5MB | 0.406 | ||||
ENC004352 | 0.353 | D01UXC | 0.402 | ||||
ENC004353 | 0.353 | D0KD1U | 0.402 | ||||
ENC004355 | 0.352 | D0I2MK | 0.398 | ||||
ENC004354 | 0.352 | D09SSC | 0.396 | ||||
ENC000071 | 0.347 | D03XTC | 0.375 |